Annual Shareholders Equity
$179.25 M
-$92.16 M-33.96%
31 December 2023
Summary:
Monte Rosa Therapeutics annual stockholders equity is currently $179.25 million, with the most recent change of -$92.16 million (-33.96%) on 31 December 2023. During the last 3 years, it has risen by +$227.98 million (+467.86%). GLUE annual shareholders equity is now -48.42% below its all-time high of $347.51 million, reached on 31 December 2021.GLUE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$205.46 M
-$19.21 M-8.55%
30 September 2024
Summary:
Monte Rosa Therapeutics quarterly stockholders equity is currently $205.46 million, with the most recent change of -$19.21 million (-8.55%) on 30 September 2024. Over the past year, it has increased by +$20.93 million (+11.34%). GLUE quarterly shareholders equity is now -44.37% below its all-time high of $369.31 million, reached on 30 September 2021.GLUE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.0% | +11.3% |
| 3 y3 years | +467.9% | -44.4% |
| 5 y5 years | - | - |
GLUE Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -48.4% | +467.9% | -44.4% | +34.7% |
| 5 y | 5 years | -48.4% | +467.9% | -44.4% | +438.9% |
| alltime | all time | -48.4% | +467.9% | -44.4% | +438.9% |
Monte Rosa Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $205.46 M(-8.6%) |
| June 2024 | - | $224.67 M(+47.3%) |
| Mar 2024 | - | $152.52 M(-14.9%) |
| Dec 2023 | $179.25 M(-34.0%) | $179.25 M(-2.9%) |
| Sept 2023 | - | $184.52 M(-13.6%) |
| June 2023 | - | $213.65 M(-12.3%) |
| Mar 2023 | - | $243.73 M(-10.2%) |
| Dec 2022 | $271.41 M | $271.41 M(-6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $291.09 M(-3.6%) |
| June 2022 | - | $302.05 M(-7.3%) |
| Mar 2022 | - | $325.88 M(-6.2%) |
| Dec 2021 | $347.51 M(-813.2%) | $347.51 M(-5.9%) |
| Sept 2021 | - | $369.31 M(+3.5%) |
| June 2021 | - | $356.68 M(-688.4%) |
| Mar 2021 | - | -$60.62 M(+24.4%) |
| Dec 2020 | -$48.73 M(+301.1%) | -$48.73 M |
| Dec 2019 | -$12.15 M | - |
FAQ
- What is Monte Rosa Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual shareholders equity year-on-year change?
- What is Monte Rosa Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly shareholders equity year-on-year change?
What is Monte Rosa Therapeutics annual stockholders equity?
The current annual shareholders equity of GLUE is $179.25 M
What is the all time high annual shareholders equity for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual stockholders equity is $347.51 M
What is Monte Rosa Therapeutics annual shareholders equity year-on-year change?
Over the past year, GLUE annual stockholders equity has changed by -$92.16 M (-33.96%)
What is Monte Rosa Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of GLUE is $205.46 M
What is the all time high quarterly shareholders equity for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly stockholders equity is $369.31 M
What is Monte Rosa Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, GLUE quarterly stockholders equity has changed by +$20.93 M (+11.34%)